Baysient Launches iDose® GEN7.0, Expanding Precision Dosing Platform to 16 Inflammatory Disease Indications
PR Newswire —
Next-Generation Decision Support Software Introduces Predictive Clinical Tools for Gastroenterology, Rheumatology, Dermatology, and Pulmonology FORT MYERS, Fla., Feb. 3, 2026 /PRNewswire/ -- Baysient®, a leader in precision medicine technology, today announced the commercial launch of...